Skip to main content
. 2003 Jan 10;546(Pt 3):891–901. doi: 10.1113/jphysiol.2002.034488

Table 2.

Fetal arterial blood gas status during acute hypoxaemia with and without the NPY-Y, receptor antagonist

Normoxia Hypoxaemia Recovery



N15 N45 H15 H45 R15 R45
PHa Saline 7.35 ± 0.01 7.35 ± 0.01 7.32 ± 0.02 7.27 ± 0.02* 7.25 ± 0.03* 7.28 ± 0.01*
Antagonist 7.34 ± 0 7.34 ± 0 7.31 ± 0.02 7.28 ± 0.04* 7.25 ± 0.02* 7.27 ± 0.02*
Pa,CO2 (mmHg) Saline 51.0 ± 1.8 51.7 ± 1.5 51.2 ± 1.4 51.7 ± 0.7 49.5 ± 1.5 50.0 ± 1.3
Antagonist 51.6 ± 0.9 51.4 ± 0.6 52.4 ± 1.1 52.6 ± 1.3 51.4 ± 1.1 49.6 ± 0.9
Pa,O2 (mmHg) Saline 21.3 ± 0.9 21.7 ± 0.8 11.8 ± 0.3* 12.2 ± 0.3* 23.3 ± 1.7 21.3 ± 1.6
Antagonist 22.2 ± 0.8 22.2 ± 1.0 11.8 ± 0.4* 12.4 ± 0.6* 25.6 ± 1.2 21.6 ± 1.9
ABE (mequiv 1−1) Saline 2.0 ± 0.3 2.0 ± 0.3 −0.5 ± 0.8 −4.7 ± 1.3* −8.2 ± 2.0* −4.8 ± 1.5*
Antagonist 1.8 ± 0.5 1.4 ± 0.4 −0.4 ± 0.7 −4.4 ± 1.8* −9.6 ± 1.3* −5.8 ± 0.9*
Sat. Hb (%) Saline 61.6 ± 2.9 62.7 ± 2.3 29.4 ± 1.6* 30.3 ± 1.9* 58.2 ± 3.4 57.5 ± 3.5
Antagonist 60.5 ± 1.1 58.6 ± 2.5 30.2 ± 1.7* 28.9 ± 1.9* 59.9 ± 2.1 56.5 ± 3.3
Hb (g dl−1) Saline 8.9 ± 0.5 8.9 ± 0.5 9.9 ± 0.5* 9.7 ± 0.5* 8.6 ± 0.5 8.3 ± 0.4
Antagonist 8.0 ± 0.4 8.5 ± 0.4 9.4 ± 0.4* 9.5 ± 0.3* 8.7 ± 0.3 8.7 ± 0.3

Values are means ± s.e.m. taken at 15 (N15) and 45 (N45) minutes of normoxia, 15 (H15) and 45 (H45) minutes of hypoxaemia and 15 (R15) and 45 (R45) minutes of recovery for 5 fetuses during vehicle infusion and during treatment with the selective NPY-Y1 receptor antagonist. Treatment started 20 min prior to the onset of acute hypoxaemia and ran continuously until the end of the hypoxaemic challenge (bar). Significant differences are:

*

P < 0.05, differences by post-hoc analysis indicating a significant main effect of time (one-way repeated measures ANOVA + Tukey test).

pHa, arterial pH; Pa,CO2 arterial CO2 partial pressure; Pa,O2, arterial O2 partial pressure; ABE, acid–base excess; Sat. Hb., percentage saturation of haemoglobin with oxygen; Hb, haemoglobin concentration.